Medical appliance maker Medtronic, Inc. (Minneapolis, MN, U.S.) has announced the appointment of William A. Hawkins as president and COO, effective immediately. Mr. Hawkins will have responsibility for the company's worldwide product line and geographic operating businesses and will report directly to Art Collins, Medtronic's chairman and CEO.
Mr. Hawkins joined the company in January 2002 as Senior Vice President and President of Medtronic's vascular business and currently serves as a member of the company's Executive Committee. He is credited with rebuilding Medtronic's vascular organization and product pipeline while repositioning the business for future growth.
Prior to joining Medtronic, Mr. Hawkins held various executive roles including President and CEO of Novoste; corporate vice president and president of Sherwood Davis & Geck at American Home Products; President of Ethicon Endo-Surgery at Johnson & Johnson; and president, Vascular Intervention and U.S. Operations for Guidant. Mr. Hawkins also spent 10 years in various leadership positions at Eli Lilly culminating as the president and CEO of Ivac Corporation. He received his B.S. degree in electrical engineering and biomedical engineering from Duke University and obtained his MBA from the University of Virginia, Darden School of Business.
In related organization announcements, Scott Ward was named to replace Mr. Hawkins as president of Medtronic's Vascular Business Unit, and Steve Mahle was promoted to executive vice president. Mr. Ward previously was responsible for Medtronic's neurological and diabetes businesses. Mr. Mahle continues to be responsible for Medtronic's cardiac rhythm management business.
Back to Breaking News